SciGene Awarded QTDP Grant for Automated Genetic Analysis System

Sunnyvale, CA – SciGene, a developer of instruments that automate the sample processing workflow used for microarray based tests, announced today that it has been awarded a grant in excess of $240,000 under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance development of an automated genetic analysis system for a variety of human diseases.

About SciGene

SciGene (www.scigene.com) is a privately held company founded in 2003 that develops instruments that automate workflows used with microarray-based procedures in research and clinical diagnostic laboratories. SciGene instruments use automation and protocol optimization to enhance the quality of FISH and microarray-based diagnostic tests.

< | >